News About: Pharm. Industry
Novartis research head visits International Vaccine Institute
Dr. Paul Herrling, head of corporate Research, Novartis Inc., visited Dr. Cecil Czerkinsky, Deputy Director-General of International Vaccine Institute (IVI) on October 9, to discuss the promotion of vaccine science fo...
Wyeth Korea works to stage strike over wage
The labor union of Wyeth Korea decided to launch a strike on October 10, after it rejected a mediation proposal by the Seoul Regional Labor Relations Commission.
Roughly 90 percent of all union members favored the ...
Pfizer CEO visits health ministry
Jeffrey B. Kindler, chairman and CEO of the pharmaceutical firm Pfizer, had an informal meeting with Korea’s Health and Welfare Minister Jeon Jae-hee on October 9 during his visit to Korea last week.
According to t...
Wyeth Korea unionists reject pay deal
A 5.5-percent wage hike proposal, which was finally made by the Seoul Regional Labor Relations Commission (SRLRC) on October 9, was rejected by union members of Wyeth Korea, creating a divisive dispute between labor a...
Kang Dong-suk concert for hope for world without hepatitis B
World-renowned violinist Kang, who is an honorary ambassador to combat hepatitis B, organizes this annual charity concert under the theme “love and friendship”, now in its ninth year.
The concert aims to give hope...
Bayer's novel anticoagulant Xarelto approved in EU
The European Commission has granted marketing approval for Xarelto (rivaroxaban), a novel anticoagulant taken as one tablet, once-daily, for the prevention of venous blood clots in adult patients undergoing elective (...
Insurance price of Evista to be lowed by 20%
Lilly Korea has announced that its price of Evista (raloxifene hydrochloride) will be reduced by 20 percent from next month due to launching of generic versions.
The company is considering no compensation for small...
Falling won affects drugmakers
The Korean won's freefall against the dollar is taking a toll on the nation's pharmaceutical firms who are suffering difficulties caused by the drastic decline in the local currency's value. The local currency slumped...
W355 bil. anti-inflammatory & analgesic agents market warms up
The competitive 355 billion won market for anti-inflammatory & analgesic drugs is set to heat up as Daewon Pharm is rushing into the game selling its homegrown Peluvi tablets (felubiprofen) at hospitals nationwide.
...
Drug makers dogged by rebate issue
Prospects have been grim for Korean pharmaceutical firms, as they are getting pressed by multinationals' increasing market presence and the government's pressure to lower drug costs. Generic drugs have long been the c...
